Back

Percutaneous Auricular Nerve Stimulation for Treating Post-COVID Fatigue (PAuSing-pCF)

Germann, M.; Maffitt, N. J.; Burton, O. A.; Ashhad, A.; Baker, A. M. E.; Cherlin, S.; Shahmandi, M.; Charlton, N.; Baker, A. S.; Zaaimi, B.; Ng, W.-F.; Soteropoulos, D. S.; Baker, S. N.; Wason, J. M. S.; Baker, M. R.

2026-01-02 neurology
10.64898/2025.12.30.25343085 medRxiv
Show abstract

Even mild SARS-CoV-2 infection can lead to post-COVID syndrome, 70% of such patients have post-COVID fatigue (pCF). Many physiological abnormalities observed in pCF could be explained by reduced vagus nerve activity. The vagus nerve, central to metabolic and inflammatory homeostasis, can be activated non-invasively by transcutaneous auricular vagus nerve stimulation (taVNS). Can taVNS improve symptoms in pCF? Data were collected from a randomized study including 114 individuals with pCF. They completed 16 weeks of daily home-based active, sham, or placebo taVNS. Data on subjective fatigue, captured by a Visual Analogue Scale (VAS), and objective measures of cortical excitability, muscle fatigue and autonomic function were collected. In participants meeting minimum adherence ([≥]1 h/day on [≥]50% of days), VAS and peripheral fatigue improved significantly after 8 weeks of active (but not sham or placebo) taVNS (11.9 {+/-} 17.8 points improvement, p=0.003, N=24). These results support taVNS as a potential therapy for pCF.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.